Cynata Therapeutics Limited Stock Price on November 7, 2024
CYYNF Stock | USD 0.19 0.00 0.00% |
If you're considering investing in Cynata Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Cynata Therapeutics stands at 0.19, as last reported on the 11th of December 2024, with the highest price reaching 0.19 and the lowest price hitting 0.19 during the day. We have found three technical indicators for Cynata Therapeutics Limited, which you can use to evaluate the volatility of the firm.
Cynata Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.
Cynata |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
CYYNF |
Based on monthly moving average Cynata Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cynata Therapeutics by adding Cynata Therapeutics to a well-diversified portfolio.
Related Headline
NRX Pharmaceuticals Headline on 7th of November 2024
NRx Pharmaceuticals, Inc. to Report Third Quarter and Year t... by finance.yahoo.com
NRx Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, today announced that it will release its third quarter and year to date 2024 financial results after the market closes on Thursday, November 14, 2024, via press release, which will be available on the Companys website at httpsir.nrxpharma.com. The Company will host a conference call to discuss the financial results as well as provide a corporate update at 430pm ET th
Cynata Therapeutics Valuation on November 7, 2024
It is possible to determine the worth of Cynata Therapeutics on a given historical date. On November 7, 2024 Cynata was worth 0.19 at the beginning of the trading date compared to the closed value of 0.19. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Cynata Therapeutics pink sheet. Still, in general, we apply an absolute valuation method to find Cynata Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cynata Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Cynata Therapeutics' related companies.
Open | High | Low | Close | Volume | |
0.19 | 0.19 | 0.19 | 0.19 | 1.00 | |
11/07/2024 | 0.19 | 0.19 | 0.19 | 0.19 | 1.00 |
0.19 | 0.19 | 0.19 | 0.19 | 1.00 |
Backtest Cynata Therapeutics | | | Cynata Therapeutics History | | | Cynata Therapeutics Valuation | Previous | Next |
Cynata Therapeutics Trading Date Momentum on November 7, 2024
On November 08 2024 Cynata Therapeutics Limited was traded for 0.19 at the closing time. The highest daily price throughout the period was 0.19 and the lowest price was 0.19 . There was no trading activity during the period 1.0. Lack of trading volume on 11/08/2024 did not affect price variability. The overall trading delta to current closing price is 0.00% . |
Cynata Therapeutics Fundamentals Correlations and Trends
By evaluating Cynata Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Cynata Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Cynata financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Cynata Therapeutics Pink Sheet history
Cynata Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cynata is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cynata Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cynata Therapeutics stock prices may prove useful in developing a viable investing in Cynata Therapeutics
Cynata Therapeutics Limited, together with its subsidiaries, develops and commercializes a proprietary mesenchymal stem cell technology under the Cymerus brand for human therapeutic use in Australia. Cynata Therapeutics Limited was founded in 2011 and is based in Cremorne, Australia. Cynata Therapeutics operates under Biotechnology classification in the United States and is traded on OTC Exchange.
Cynata Therapeutics Pink Sheet Technical Analysis
Cynata Therapeutics technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Price Boundaries
Cynata Therapeutics Period Price Range
Low | December 11, 2024
| High |
0.00 | 0.00 |
Cynata Therapeutics Limited cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Cynata Therapeutics December 11, 2024 Market Strength
Market strength indicators help investors to evaluate how Cynata Therapeutics pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cynata Therapeutics shares will generate the highest return on investment. By undertsting and applying Cynata Therapeutics pink sheet market strength indicators, traders can identify Cynata Therapeutics Limited entry and exit signals to maximize returns
Complementary Tools for Cynata Pink Sheet analysis
When running Cynata Therapeutics' price analysis, check to measure Cynata Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cynata Therapeutics is operating at the current time. Most of Cynata Therapeutics' value examination focuses on studying past and present price action to predict the probability of Cynata Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cynata Therapeutics' price. Additionally, you may evaluate how the addition of Cynata Therapeutics to your portfolios can decrease your overall portfolio volatility.
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |